Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 221 - 230 of 238 results for "Pharmaceutical"

Market wrap

The Australian share market is expected to open sharply weaker as a poor lead from stock markets across the world is expected to feed into the local market this morning. With commodity prices essentially treading water overnight, Australian investors ...

Market Wrap

AAP  |  TUESDAY, 27 SEP 2005
... Network against 22 media, telco and sporting bodies over the demise of C7 in May 2002, continues while Australian Pharmaceutical Industries hosts its annual general meeting. NEW YORK - US stocks edged up as a jump in oil prices sparked gains in energy ...

Market wrap

AAP  |  TUESDAY, 23 AUG 2005
The Australian share market will likely open little changed today with investor attention turning to further earnings reports from local companies after a subdued performance on Wall Street overnight. It will take little for the market to hit a fresh ...

Market wrap

AAP  |  MONDAY, 27 JUN 2005
... September share price index contract was 21 points weaker at 4242 on a volume of 826 contracts. Today Australian Pharmaceutical Industries reveals its full year results while the Housing Industry Association releases its June quarter report.

Market wrap

AAP  |  MONDAY, 21 MAR 2005
... On the Sydney Futures Exchange, the June share price index contract was three points lower to 4268. On the day pharmaceutical company Sigma will unveil full year results while Westralian Gas and Power Ltd is due to list on the ASX.

Record IPO Activity: It's crazy out there says Deloitte

Deloitte's latest IPO report has revealed a record breaking year for IPOs with an unprecedented 176 newly floated companies raising a total of $10.4 billion. "It's crazy out there. It's hard to tell whether we're at the top of the cycle but the next ...

Soul Pattinson branches out into superannuation

AAP  |  WEDNESDAY, 6 OCT 2004
... superannuation market. Soul Pattinson already has a portfolio of investments in the building, mining, media, financial, pharmaceutical and food industries worth $1.91 billion. Chairman Mr Rob Millner said he was inspired to move into superannuation because ...

Emerging opportunities not just in China: Franklin Templeton

US-based investment house Franklin Templeton on Thursday said superannuation and investment flows into Brazil, Russia and India as well as China (BRIC) could soon set new records. A white paper released by Franklin Templeton Institutional, Finding Opportunities ...

Labor to support FTA with US

AAP  |  TUESDAY, 3 AUG 2004
... legislation. But left-wing MPs and senators argued against the agreement, concerned about the FTA\'s impact on pharmaceutical prices and jobs. The decision to support the trade deal is a victory for Opposition Leader Mark Latham, who has consistently ...

Biota to sue GlaxoSmithKline over Relenza flu drug

AAP  |  WEDNESDAY, 5 MAY 2004
Biotech Biota Holdings is suing global pharmaceutical giant GlaxoSmithKline, alleging that GSK failed to support and promote Biota's flu drug, Relenza. Biota said it had issued a writ in the Victorian Supreme Court. Biota, which licensed Relenza to ...